Building an accurate budget for a clinical trial comes with a host of challenges. These include, but are not limited to, intricate protocols, large enrollments, shortened timelines and global sites. By using IQVIA Technologies’ GrantPlan—a benchmarking tool that uses a global dataset—experts can develop Fair market Value (FMV) costs. Furthermore, costs can even be associated with the disease indication being studied. This is particularly useful in negotiating costs for investigators. GrantPlan is used by more than three-quarters of the studies currently submitted on clinicaltrial.gov.